Evaluating Adaptive Dispenser Initiation Protocols for MySafeRx During Post-detox Buprenorphine Treatment- a Pilot Study

Evaluating Adaptive Dispenser Initiation Protocols for MySafeRx During Post-detox Buprenorphine Treatment- a Pilot Study

Publication date: Jun 29, 2020

Opioid overdoses are a significant problem nationwide and novel interventions that can prevent overdose by improving buprenorphine treatment for opioid use disorder are a public health priority. This study will both investigate the effects of starting remote motivational enhancement during inpatient detoxification on rates of engagement in Buprenorphine/ Naloxone (B/N) treatment and evaluate the impact of MySafeRx, a mobile device application which integrates remote motivational coaching with daily observed dosing from secure electronic pill dispensers at home via videoconference, on treatment retention and overdose prevention. Broad dissemination of this new intervention could help communities across the nation expand and advance their capacity to increase B/N treatment engagement and retention, enhance medication adherence, and prevent overdose.

Concepts Keywords
Aim Innovative opioid disorder
Android Inpatient detox services
Buprenorphine Opioids
County Drugs
Detox Psychoactive drugs
Detoxification RTT
Differential Morphinans
Incidence Euphoriants
Infection Pharmacy
Mobile Device Tertiary alcohols
MOCA Buprenorphine
Naloxone Adherence
Opioid Naloxone
Opioid Overdose Pill dispenser
Overdose Video conferencing
Smartphone Smartphone
South Florida Android
Toxicology Mobile device
Urine
Videoconference
Videoconferencing

Semantics

Type Source Name
drug DRUGBANK Buprenorphine
drug DRUGBANK Naloxone
disease MESH communities
disease MESH medication adherence

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *